Skip to content
T5T5T5

Drawing based on the description in the official product monograph. No photo yet.

“Table 4:. Dosage Forms, Strengths,. Composition and Packaging Route of Administration Oral Dosage Form / Strength /. Composition Tofacitinib tablets 5 mg (as tofacitinib citrate) Non-medicinal Ingredients Croscarmellose Sodium, Hypromellose, Lactose Monohydrate, Magnesium Stearate, Microcrystalline Cellulose, Polyethylene glycol, Titanium Dioxide. pms-TOFACITINIB Tablet: 5 mg tofacitinib (as tofac”

T5 pill

Pill with imprint T5 is white, round and has been identified as Tofacitinib Citrate 5 mg. It is used for rheumatoid arthritis. It is supplied by Pharmascience Inc.

Sold in Canada

Tofacitinib Citrate 5 mg

Brand
PMS-Tofacitinib
Imprint
T5
Strength
5 mg
Used for
Rheumatoid arthritis
Color
White
Shape
Round
Form
Tablet
Manufacturer
Pharmascience Inc
Drug class
Cancer medicine (kinase inhibitor)
Sold in
Canada
DIN
02522799

Source: Health Canada's Drug Product Database and the official product monograph. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Tofacitinib pills and guides

What is Tofacitinib used for?

Tofacitinib is used for rheumatoid arthritis.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Rheumatoid Arthritis

Tofacitinib extended-release tablets are indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA), who have had an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use

Use of tofacitinib extended-release tablets in combination with biologic disease-modifying antirheumatic drugs (DMARDs) or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

Psoriatic Arthritis

Tofacitinib extended-release tablets are indicated for the treatment of adults with active PsA who have had an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use

Use of tofacitinib extended-release tablets in combination with biologic DMARDs or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

Ankylosing Spondylitis

Tofacitinib extended-release tablets are indicated for the treatment of adult patients with active ankylosing spondylitis (AS), who have had an inadequate response or intolerance to one or more TNF blockers.

Limitations of Use

Use of tofacitinib extended-release tablets in combination with biologic DMARDs or potent immunosuppressants such as azathioprine and cyclosporine is not recommended.

From the FDA-approved label on DailyMed (published Oct 05, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows T5.
  • It is white, round.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold in Canada as PMS-Tofacitinib by Pharmascience Inc.

In Canada: prescription only.

Ingredients

Active: Tofacitinib (Tofacitinib Citrate)

Other pills with imprint T 5

Same imprint, different listing. Check the color, size and maker against your pill.

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Tofacitinib pills